Research Suggests DNA Screenings To Improve Mesothelioma Treatment

A new study shows how cells respond to chemotherapy treatment. The screening for DNA damage may help patients with malignant pleural mesothelioma receive a more effective treatment response. Currently with patients receiving chemotherapy treatment for mesothelioma, the disease appears to occur again within months.

Many drugs being tested in studies have helped researchers and scientist understand more about how the mesothelioma cells change and ultimately have been developing newer drugs to focus on the changes.

Scientists have also been conducting studies on attempting to kill cancer cells by adding new genes to slower the mesothelioma spread. With each patient reacting differently to all forms of treatments available makes mesothelioma a very difficult disease to treat. In other treatment studies and clinical trials immunotherapy treatment has also produced promise in getting the patients immune system to attack the cancer. Removing a patients immune cells from the blood and given back after treated hopes to have the patients immune system to fight off the cancer.

Understanding the cause of Mesothelioma

Scientist are focused on how asbestos fibers can form such a unique type of cancer. Understanding the symptoms of mesothelioma and researching more enhanced ways to prevent this disease, will overall help with diagnosis and treatments.

With well over 80 percent of patients diagnosed with mesothelioma, asbestos exposure being the main factor in their diagnosis. There are six types of asbestos, but chrysotile in know for more than 90 percent of all asbestos used worldwide. Scientist better understand what asbestos fibers are causing mesothelioma. The clinical trials that study the damaged cells through a pre-screening process are hoping to enhance the treatments with early symptoms of mesothelioma.

Chemotherapy for Mesothelioma Currently

Treating to shrink a tumor related to the mesothelioma diagnosis before surgery may reduce the spread of the cancer. Mesothelioma still remains a very difficult cancer to treat, but clinical studies are constantly being enhanced to better patients overall treatment options. These new studies and types of treatments have hope to give doctors and each of their patients more effective options.

Clinical trials dedicated to develop a clearer understanding of mesothelioma

With such a long latency period for the disease and the continued consumption of asbestos related products, it seems the future of asbestos exposure will surely continue throughout the 20th century. Scientists and researchers understand the importance of finding new hopes for the treatments of mesothelioma. Dedicated in finding symptoms for an early diagnosis and a enhanced way to manage the disease.